AI Imaging Tools Revolutionizing Patient Care in Health Systems
AI imaging tools enhance patient care, improving follow-up rates and outcomes in health systems. 🤖📈
October 25, 2024
Follow us
latest articles
Discover the newest research about AI innovations in 🎗 Oncology.
Machine learning applications in breast cancer survival and therapeutic outcome prediction based on multi-omic analysis.
Machine learning enhances breast cancer treatment by analyzing multi-omic data for better survival predictions and personalized strategies. 📊💡
October 24, 2024
Revolutionizing Cancer Treatment: AI-Driven Personalized Vaccine Development
AI-driven NeoDisc pipeline enhances personalized cancer vaccine development, integrating molecular analyses for improved patient outcomes. 🧬💉
October 23, 2024
An optimal fast fractal method for breast masses diagnosis using machine learning.
A new fast fractal method enhances breast cancer diagnosis accuracy and speed using machine learning. 📊💡
October 22, 2024
Innovative AI Software Enhances Cancer Immunotherapy Development
AI software enhances cancer immunotherapy development, enabling label-free analysis of cell behavior for improved treatment insights. 🧬💻
October 15, 2024
DETECTION OF ORAL SQUAMOUS CELL CARCINOMA USING PRE-TRAINED DEEP LEARNING MODELS.
Recent research highlights the use of deep learning models for early detection of oral squamous cell carcinoma. 🦷📊
October 14, 2024
Smart variant filtering – A blueprint solution for massively parallel sequencing-based variant analysis.
Massively parallel sequencing enhances genomic insights but complicates clinical decisions. 🤖 A new AI-based solution aims to streamline variant analysis. 🧬
October 13, 2024
NHS Trusts Receive £30 Million for Advanced Medical Technology and Research
NHS trusts receive £30 million for advanced medical technology and research. 🏥💰 This funding aims to enhance patient care and expand research capabilities. 📈🔬
October 11, 2024
Machine learning-based discovery of UPP1 as a key oncogene in tumorigenesis and immune escape in gliomas.
Recent research highlights UPP1’s role in glioma progression and immune evasion. Promising target for future therapies. 🧠🔬
October 9, 2024
Machine learning based intratumor heterogeneity signature for predicting prognosis and immunotherapy benefit in stomach adenocarcinoma.
A recent PubMed article explores a machine learning signature for predicting outcomes in stomach adenocarcinoma. 📊🔬
October 9, 2024